Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda PharmaceuticalfiledCriticalTakeda Pharmaceutical
Priority to DO2009000081ApriorityCriticalpatent/DOP2009000081A/en
Publication of DOP2009000081ApublicationCriticalpatent/DOP2009000081A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
El propósito de la presente invención es proporcionar un activador de glucocinas átil como un agente farmacéutico tal como un agente para la profilaxis o tratamiento de diabetes, obesidad y similar. La presente invención proporciona un activador de glucocinasa que contiene un compuesto representado por la fórmula (1): en donde R1 es un átomo de hidrogeno o un átomo de halógeno, R2 es un grupo representado en donde cada sámolo se define eb la especificación, o su sal o su profármaco.The purpose of the present invention is to provide an active glucokine activator as a pharmaceutical agent such as an agent for the prophylaxis or treatment of diabetes, obesity and the like. The present invention provides a glucokinase activator containing a compound represented by the formula (1): wherein R 1 is a hydrogen atom or a halogen atom, R 2 is a represented group in which each samolo is defined in the specification, or its salt or its prodrug.
DERIVATIVES OF PIRIMIDIL-PIPERIDINIL-OXIPIRIDINONA, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME TO TREAT DIABETES, DYSLIPEMIAS, OBESITY AND OTHER DISEASES